Defends against cerebral ischemia/reperfusion injury by inhibiting the NLRP3 inflammasome, while suppressing the MAPK pathway and activating the PI3K/AKT signaling cascade, thereby mitigating cerebral infarction and neurological deficits. The gene discussed is AKT1; the disease is brain infarction.